| Filed | Form | Description | |
|---|---|---|---|
| 11/14/24 | SC 13G/A | SC 13G/A | → |
| 4/19/24 | SC 13G | SC 13G | → |
| 2/14/24 | SC 13G/A | SC 13G/A | → |
| 11/22/23 | SC 13G | SC 13G | → |
| 10/30/23 | SC 13G | SC 13G | → |
| 10/30/23 | SC 13D | SC 13D | → |
Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.